期刊文献+

入院时尿酸水平与急性心肌梗死患者预后的相关性分析 被引量:3

Relationship between gigher serum uric acid on admission and prognosis after acute myocardial infarction
下载PDF
导出
摘要 目的评估急性心肌梗死(AMI)患者入院时的血清尿酸(SUA)水平与其短期死亡率及长期生存率之间的相关性。方法连续入选该院CCU收治的症状发作48h之内的AMI患者,记录入院时的SUA及其他实验室检查结果。主要终点为短期(住院期间或症状首次发作30d内)死亡率,次要终点为远期(出院后或症状首次发作30d后)全因死亡率。结果共入选523名患者,男性312例,女性211例,平均(67.3±15.6)岁。校正其他危险因素后,入院时高的SUA水平与AMI后高的住院死亡率(RR,1.016;95%CI,1.001-1.031,P=0.043)、高的30 d死亡率(RR,1.016;95%CI,1.003-1.029,P=0.018)、以及远期生存率的下降(HR,1.105;95%CI,1.020-1.195,P=0.010)独立相关。结论入院时(症状发作48h内)高的SUA与AMI后高的短期死亡率和低的远期生存率相关。 【Objective】 To assess serum uric acid(SUA) levels determined on admission as a potential predictor of short-term mortality and long-term survival in acute myocardial infarction(AMI) patients.【Method】 We included consecutive patients with verified AMI admitted within 48 hours since the symptom onset.The primary end point was short-term mortality(in-hospital and thirty-day),secondary end points were long-term survival(long-term all-cause mortality).【Result】 A total of 523 patients(312 men,age 67.3±15.6 years) were included.Higher SUA on admission was independently associated with higher in-hospital mortality(RR,1.016;95%CI,1.001-1.031,P =0.043) and higher thirty-day mortality(RR,1.016;95%CI,1.003-1.029,P =0.018).Higher SUA on admission was also independently associated with poorer long-term survival(higher all-cause mortality)(HR,1.105;95% CI,1.020-1.195,P =0.010).【Conclusion】 Higher serum uric acid on admission is associated with higher short-term mortality and poorer long-term survival after AMI.
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2011年第7期814-817,共4页 China Journal of Modern Medicine
关键词 急性心肌梗死 尿酸 预后 acute myocardial infarction uric acid prognosis
  • 相关文献

参考文献16

  • 1COLEMAN LA, ROUBENOFF R. Gout[M]// Caballero B, Allen L Prentice A. Encyclopedia of human nutrition. 2nd ed. Oxford (ILK): Elsevier, 2005: 419-423.
  • 2VITART V, RUDAN I, HAYWARD C, et al. SLC2A9 is a newly identified urate transporter influencing serum urate con- centration, urate excretion and gout [J]. Nat Gene4 2008, 40: 437-442.
  • 3FEIG DI, KANG DH, JOHNSON RJ. Uric acid and cardiovaseu- lax risk[J]. N Engl J Med, 2008, 359: 1811-1821.
  • 4TOMITA M, MIZUNO S, YOKOTA K. Increased levels of serum uric acid among ex-smokers[J]. J Epidemiol. 2008, 18: 132-134.
  • 5ALLISON TG. Coronary heart disease epidemiology[M].// Murphy JG, Lloyd MA. Mayo clinic cardiology. 3rd ed. Rochester (iN): Mayo Clinic Scientific Press, 2007: 687-93.
  • 6BRODOV Y, CHOURAQUI P, GOLDENBERG I, et al. Serum uric acid for risk stratification of patients with coronary artery disease[J]. Cardiology, 2009, 114: 300-305.
  • 7DUNKELGRUN M, WELTEN GM, GOEI D, et al. Association between serum uric acid and perioperative and late cardiovascu- lar outcome in patients with suspected or definite coronary artery disease undergoing elective vascular surgery [J]. Am J Cardiol, 2008, 102: 797-801.
  • 8FEIG DI, KANG DH, JOHNSON RJ. Uric acid and eardiovascu" lar risk[J]. N Engl J Med, 2008, 359: 1811-1821.
  • 9JOHNSON R J, KANG DH, FEIG D, et al. Is there a pathogenetic role for uric acid in hypertension and cardiovascular andrenal disease? [J] Hypertension, 2003, 41: 1183-1190.
  • 10GAGLIARDI AC, MINAME MH, SANTOS RD. Uric acid: A marker of increased cardiovascular risk[J]. Atherosclerosis, 2009, 202:11-17.

同被引文献40

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部